RTI Surgical to Acquire Collagen Solutions
RTI Surgical announces the acquisition of Collagen Solutions to enhance its regenerative medicine offerings.
RTI Surgical has announced its plan to acquire Collagen Solutions, a strategic decision aimed at enhancing its regenerative medicine capabilities. This acquisition will expand RTI's expertise in collagen-based medical devices and tissue products, allowing the company to leverage Collagen Solutions' established technologies and knowledge in the field.
The transaction is expected to close in the fourth quarter of 2024, pending regulatory approvals. This move demonstrates RTI's commitment to innovation and its goal of improving patient outcomes in surgical and regenerative medicine.
By integrating Collagen Solutions into its operations, RTI Surgical aims to strengthen its position in the market and drive future growth. The acquisition aligns with the company’s broader strategy to develop advanced healthcare solutions that meet the evolving needs of patients and healthcare providers.
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
More from Pharma News
All stories →
Pharming Group Gains FDA Approval for Leniolisib in Children Aged 4–11 with APDS
Lonza Builds Oregon Spray-Drying Facility To Expand SDD Capacity
Discussion